Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China · Delayed Price · Currency is CNY 4.310
+0.030 (0.70%)
Jan 23, 2026, 3:00 PM CST
SHA:603363 Revenue
Fujian Aonong Biological Technology Group Incorporation had revenue of 2.38B CNY in the quarter ending September 30, 2025, with 4.79% growth. This brings the company's revenue in the last twelve months to 8.17B, down -27.07% year-over-year. In the year 2024, Fujian Aonong Biological Technology Group Incorporation had annual revenue of 8.76B, down -54.97%.
Revenue (ttm)
8.17B
Revenue Growth
-27.07%
P/S Ratio
1.37
Revenue / Employee
1.57M
Employees
5,220
Market Cap
11.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.76B | -10.69B | -54.97% |
| Dec 31, 2023 | 19.46B | -2.16B | -9.97% |
| Dec 31, 2022 | 21.61B | 3.57B | 19.82% |
| Dec 31, 2021 | 18.04B | 6.52B | 56.62% |
| Dec 31, 2020 | 11.52B | 5.73B | 98.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition